ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook

FDA Name Differentiation Project

List of Product Names and
Recommended Revisions

for the Use of Tall-Man Letters

 

Drug Product Revision Recommended
acetohexamide  acetoHEXAMIDE
acetazolamide  acetaZOLAMIDE
   
clomiphene   clomiPHENE
clomipramine  clomiPRAMINE
   
chlorpropamide  chlorproPAMIDE
chlorpromazine chlorproMAZINE
   
glipizide glipiZIDE
glyburide glyBURIDE
   
tolazamide    TOLAZamide
tolbutamide TOLBUTamide
   
vinblastine  vinBLAStine
vincristine vinCRIStine
   
dobutamine DOBUTamine
dopamine DOPamine
   
hydralazine   hydrALAZINE
hydroxyzine hydrOXYzine
   
bupropion buPROPion
buspirone   busPIRone
   
nicardipine niCARdipine
nifedipine NIFEdipine
   
sulfadiazine sulfADIAZINE
sulfisoxazole  sulfiSOXAZOLE
   
diphenhydramine  diphenhydrAMINE
dimenhydrinate dimenhyDRINATE
   
medroxyprogesterone  medroxyPROGESTERone
methylprednisolone methylPREDNISolone
methyltestosterone  methylTESTOSTERone
   
prednisone  predniSONE
prednisolone prednisoLONE
   
cyclosporine  cycloSPORINE
cycloserine cycloSERINE
   
daunorubicin DAUNOrubicin
doxorubicin DOXOrubicin

 

Resources
Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Subscribe
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Long Term Care
Consumer
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2017 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP